US FDA inspection at the manufacturing facility (Oncology) located at Sanand, Ahmedabad, Gujarat, India – 09.07.2025

Read More

Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcure Wellness Private Limited 04.07.2025

Read More

Intimation under Regulation 31A of the SEBI Listing Regulations – Submission of application for seeking re-classification from the ‘Promoter and Promoter Group’ category to ‘Public’ category

Read More

Intimation under Regulation 30 – Regulatory Order received on 24.06.2025

Read More

Intimation under Regulation 31A of the SEBI Listing Regulations – Outcome of the meeting of the Board of Directors considering requests for re-classification from the ‘Promoter and Promoter Group’ category to ‘Public’ category

Read More

Intimation under Regulation 30 – Proposed Incorporation of wholly-owned Subsidiary – Emcure Wellness Private Limited 21.06.2025

Read More

Intimation under Regulation 30 – Acquisition of Equity Shares of Zuventus Healthcare Limited, Subsidiary 21.06.2025

Read More

Outcome of Board Meeting held on 21.06.2025

Read More

Intimation under Regulation 31A – Receipt of requests of re-classification from the ‘Promoter and Promoter Group’ category to ‘Public’ category 19.06.2025

Read More

Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcure Lifesciences Private Limited 17.06.2025.

Read More
Next